Ensysce Biosciences Stock Z Score
| ENSC Stock | USD 0.58 0.05 7.94% |
Ensysce | Z Score |
Ensysce Biosciences Company Z Score Analysis
Ensysce Biosciences' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
| |||||||
| |||||||
| |||||||
| |||||||
|
Ensysce Z Score Driver Correlations
Understanding the fundamental principles of building solid financial models for Ensysce Biosciences is extremely important. It helps to project a fair market value of Ensysce Stock properly, considering its historical fundamentals such as Z Score. Since Ensysce Biosciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Ensysce Biosciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Ensysce Biosciences' interrelated accounts and indicators.
Click cells to compare fundamentals
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
| Competition |
According to the company's disclosures, Ensysce Biosciences has a Z Score of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The z score for all United States stocks is 100.0% higher than that of the company.
Ensysce Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ensysce Biosciences' direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ensysce Biosciences could also be used in its relative valuation, which is a method of valuing Ensysce Biosciences by comparing valuation metrics of similar companies.Ensysce Biosciences is currently under evaluation in z score category among related companies.
Ensysce Biosciences Institutional Holders
Institutional Holdings refers to the ownership stake in Ensysce Biosciences that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Ensysce Biosciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Ensysce Biosciences' value.| Shares | Gsa Capital Partners Llp | 2023-09-30 | 0.0 | Two Sigma Securities, Llc | 2023-12-31 | 0.0 | Bank Of America Corp | 2023-12-31 | 0.0 | Citadel Advisors Llc | 2023-09-30 | 19.1 K | Vanguard Group Inc | 2023-12-31 | 18.2 K | Geode Capital Management, Llc | 2023-12-31 | 16.3 K | Renaissance Technologies Corp | 2023-12-31 | 11 K | Tower Research Capital Llc | 2023-12-31 | 6.3 K | Blackrock Inc | 2023-12-31 | 975 | Wells Fargo & Co | 2023-12-31 | 24.0 | Ubs Group Ag | 2023-12-31 | 3.0 |
Ensysce Fundamentals
| Return On Equity | -13.2 | ||||
| Return On Asset | -1.56 | ||||
| Operating Margin | (6.13) % | ||||
| Current Valuation | 4.02 M | ||||
| Shares Outstanding | 7.33 M | ||||
| Shares Owned By Insiders | 5.55 % | ||||
| Shares Owned By Institutions | 2.31 % | ||||
| Number Of Shares Shorted | 17.48 K | ||||
| Price To Book | 1.68 X | ||||
| Price To Sales | 2.45 X | ||||
| Revenue | 2.23 M | ||||
| Gross Profit | (1.16 M) | ||||
| EBITDA | (10.72 M) | ||||
| Net Income | (10.63 M) | ||||
| Cash And Equivalents | 3.15 M | ||||
| Cash Per Share | 0.10 X | ||||
| Total Debt | 854.7 K | ||||
| Debt To Equity | 6.91 % | ||||
| Current Ratio | 0.87 X | ||||
| Book Value Per Share | (0.10) X | ||||
| Cash Flow From Operations | (10.78 M) | ||||
| Short Ratio | 0.09 X | ||||
| Earnings Per Share | (4.69) X | ||||
| Target Price | 11.33 | ||||
| Beta | 0.76 | ||||
| Market Capitalization | 4.62 M | ||||
| Total Asset | 2.71 M | ||||
| Retained Earnings | (121.56 M) | ||||
| Working Capital | (1.04 M) | ||||
| Net Asset | 2.71 M |
About Ensysce Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ensysce Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ensysce Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ensysce Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Ensysce Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ensysce Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ensysce Biosciences will appreciate offsetting losses from the drop in the long position's value.Moving against Ensysce Stock
| 0.75 | IOVA | Iovance Biotherapeutics Financial Report 14th of May 2024 | PairCorr |
| 0.62 | NUVB | Nuvation Bio Financial Report 2nd of May 2024 | PairCorr |
| 0.61 | JSPRW | Jasper Therapeutics | PairCorr |
| 0.58 | IMMP | Immutep Ltd ADR | PairCorr |
| 0.57 | MRSN | Mersana Therapeutics Downward Rally | PairCorr |
The ability to find closely correlated positions to Ensysce Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ensysce Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ensysce Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ensysce Biosciences to buy it.
The correlation of Ensysce Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ensysce Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ensysce Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ensysce Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Ensysce Biosciences Piotroski F Score and Ensysce Biosciences Valuation analysis. For information on how to trade Ensysce Stock refer to our How to Trade Ensysce Stock guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Complementary Tools for Ensysce Stock analysis
When running Ensysce Biosciences' price analysis, check to measure Ensysce Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ensysce Biosciences is operating at the current time. Most of Ensysce Biosciences' value examination focuses on studying past and present price action to predict the probability of Ensysce Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ensysce Biosciences' price. Additionally, you may evaluate how the addition of Ensysce Biosciences to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Stocks Directory Find actively traded stocks across global markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |
Is Ensysce Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ensysce Biosciences. If investors know Ensysce will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ensysce Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.69) | Revenue Per Share 0.985 | Quarterly Revenue Growth (0.64) | Return On Assets (1.56) | Return On Equity (13.20) |
The market value of Ensysce Biosciences is measured differently than its book value, which is the value of Ensysce that is recorded on the company's balance sheet. Investors also form their own opinion of Ensysce Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Ensysce Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ensysce Biosciences' market value can be influenced by many factors that don't directly affect Ensysce Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ensysce Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ensysce Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ensysce Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.